Evolus
Sells a cosmetic-only neurotoxin and hyaluronic-acid filler line directly to physicians on a cash-pay basis.
$8.88
After-hours close−0.01 (−0.11%)
At close$8.89(+0.11%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 74.19%48.86M sharesInsiders 3.51%2.31M sharesOther 22.30%14.69M shares
Shares outstanding 65.85M · Float 50.04M · 76.0% free float
Institutions13F, as of Jun 30, 2026
167 holders · 48.86M shares · 34 new positions · 90 increased · 39 reduced · 22 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 5.60M | 8.51% | −774.8K | Aug 19, 2026 |
| BlackRock, Inc. | 4.84M | 7.35% | +550.4K | Aug 7, 2026 |
| Braidwell LP | 3.16M | 4.79% | +50.0K | Aug 14, 2026 |
| Frazier Life Sciences Management, L.P. | 2.63M | 3.99% | 0 | Aug 14, 2026 |
| Perceptive Advisors LLC | 2.46M | 3.73% | +1.17M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 2.36M | 3.59% | −107.5K | Aug 13, 2026 |
| Millennium Management LLC | 1.79M | 2.71% | +326.8K | Aug 14, 2026 |
| State Street Corp | 1.70M | 2.58% | +376.5K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Timothy P. Lynch | 9.90% | 6.43M | 13G | Feb 17, 2026 ↗ |
| Nantahala Capital Management, LLC | 8.85% | 5.73M | 13G | Nov 14, 2025 ↗ |
| BlackRock, Inc. | 6.90% | 4.36M | 13G | Feb 5, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| David Moatazedi | director, officer: See Remarks | 604.7K | 0.92% | Mar 20, 2026 |
| Rui Avelar | officer: See Remarks | 427.4K | 0.65% | Mar 20, 2026 |
| Vikram Malik | director | 321.1K | 0.49% | Feb 19, 2026 |
| Tatjana Mitchell | officer: Chief Financial Officer | 226.1K | 0.34% | Feb 19, 2026 |
| Sandra Beaver | officer: Chief Financial Officer | 167.1K | 0.25% | May 14, 2025 |
| Brady Stewart | director | 134.2K | 0.20% | Feb 19, 2026 |
| Albert G. III White | director | 95.9K | 0.15% | Feb 19, 2026 |
| Tomoko Yamagishi-Dressler | officer: Chief Marketing Officer | 89.9K | 0.14% | Aug 26, 2025 |
| David N. Gill | director | 86.9K | 0.13% | Feb 19, 2026 |
| Karah Herdman Parschauer | director | 77.7K | 0.12% | Feb 19, 2026 |
2 ten-percent owners hold 13.66M shares by Form 4, outside the officers-and-directors figure above · 8 people have not refiled in the last 18 months (707.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 20, 2026 | David Moatazedidirector, officer: See Remarks | Sale | 13,669 | $4.75 | 604,700 |
| Mar 20, 2026 | Rui Avelarofficer: See Remarks | Sale | 3,119 | $4.75 | 427,423 |
| Mar 17, 2026 | Rui Avelarofficer: See Remarks | Sale | 29,996 | $4.89 | 430,542 |
| Mar 17, 2026 | David Moatazedidirector, officer: See Remarks | Sale | 116,720 | $4.89 | 618,369 |
| Dec 22, 2025 | Rui Avelarofficer: See Remarks | Sale | 2,261 | $7.15 | 356,821 |
| Dec 22, 2025 | David Moatazedidirector, officer: See Remarks | Sale | 10,539 | $7.15 | 354,388 |
CongressHouse and Senate disclosures
Not reported.